ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

OSTX vs MNOV // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

OS Therapies Incorporated (NYSE) VS. Medicinova Inc (NASDAQ) • 15-METRIC TALLY: OSTX 0 — MNOV 4
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OSTX VS. MNOV) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC OSTX MNOV SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -21.07% -14.24% -6.83 MNOV /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — 68.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 3/9 -2.00 MNOV /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 33.8 38.4 -4.59 MNOV /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 5.3x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $67.6M $68.9M -$1.3M MNOV /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR OSTX REV MNOV REV OSTX GROSS % MNOV GROSS % OSTX FCF MNOV FCF
FY 2025 $0 $409.7K — — -$14.2M -$9.8M
FY 2024 $0 $0 — — -$7.3M -$10.6M
FY 2023 $0 $1.0M — — -$3.0M -$7.4M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OSTX // BETA —
MNOV // BETA —